HIV vaccine design: insights from live attenuated SIV vaccines
…, AB McDermott, A Schultz, TJ Zamb, R Boyle… - Nature …, 2006 - nature.com
The International AIDS Vaccine Initiative has established a consortium to elucidate mechanisms
of protection conferred by live attenuated simian immunodeficiency virus vaccines in …
of protection conferred by live attenuated simian immunodeficiency virus vaccines in …
Macaques vaccinated with live-attenuated SIV control replication of heterologous virus
…, NA Wilson, AB McDermott, R Boyle… - Journal of Experimental …, 2008 - rupress.org
An effective AIDS vaccine will need to protect against globally diverse isolates of HIV. To
address this issue in macaques, we administered a live-attenuated simian immunodeficiency …
address this issue in macaques, we administered a live-attenuated simian immunodeficiency …
Macaques vaccinated with simian immunodeficiency virus SIVmac239Δnef delay acquisition and control replication after repeated low-dose heterologous SIV …
…, R Makowsky, AB McDermott, R Boyle… - Journal of …, 2010 - journals.asm.org
An effective human immunodeficiency virus (HIV) vaccine will likely need to reduce mucosal
transmission and, if infection occurs, control virus replication. To determine whether our best …
transmission and, if infection occurs, control virus replication. To determine whether our best …
Postexposure immunoprophylaxis of primary isolates by an antibody to HIV receptor complex
…, MT Salas, M Shen, MC Gauduin, RW Boyle… - Proceedings of the …, 1999 - pnas.org
mAb B4 is a monoclonal antibody directed against HIV receptor complex. The antibody had
broad neutralizing activity against HIV and provided postexposure prophylaxis to hu–…
broad neutralizing activity against HIV and provided postexposure prophylaxis to hu–…
Phase 1 safety and immunogenicity evaluation of ADMVA, a multigenic, modified vaccinia Ankara-HIV-1 B'/C candidate vaccine
…, S Than, P Adesanya, C Bunce, M Boaz, R Boyle… - PLoS …, 2010 - journals.plos.org
Background We conducted a Phase I dose-escalation trial of ADMVA, a Clade-B'/C-based
HIV-1 candidate vaccine expressing env, gag, pol, nef, and tat in a modified vaccinia Ankara …
HIV-1 candidate vaccine expressing env, gag, pol, nef, and tat in a modified vaccinia Ankara …
Phase 1 safety and immunogenicity evaluation of ADVAX, a multigenic, DNA-based clade C/B'HIV-1 candidate vaccine
…, S Than, P Adesanya, C Bunce, M Boaz, R Boyle… - PLoS …, 2010 - journals.plos.org
Background We conducted a Phase I dose escalation trial of ADVAX, a DNA-based candidate
HIV-1 vaccine expressing Clade C/B' env, gag, pol, nef, and tat genes. Sequences were …
HIV-1 vaccine expressing Clade C/B' env, gag, pol, nef, and tat genes. Sequences were …
Synthetic-peptide-based enzyme-linked immunosorbent assay for screening human serum or plasma for antibodies to human immunodeficiency virus type 1 and type …
L Gonzalez, RW Boyle, M Zhang… - Clinical Diagnostic …, 1997 - journals.asm.org
A synthetic-peptide-based enzyme-linked immunosorbent assay (EIA) capable of screening
for antibodies to both human immunodeficiency virus type 1 (HIV-1) and HIV-2 has been …
for antibodies to both human immunodeficiency virus type 1 (HIV-1) and HIV-2 has been …
Diagnosis of chronic hepatitis C: comparison of immunoassays and the polymerase chain reaction.
AE Silva, B Hosein, RW Boyle… - American Journal of …, 1994 - search.ebscohost.com
We evaluated a series of first-and second-generation enzyme-linked immunoassays for anti-HCV
and compared the findings to those with two confirmatory assays, the recombinant …
and compared the findings to those with two confirmatory assays, the recombinant …
Will the real body please stand up?: Boundary stories about virtual cultures
SA Rosanne - Cyberspace: first steps, 1991 - degruyter.com
… the debate between Boyle and the philosopher Thomas Hobbes, Leviathan and the Air-Pump,
we probably owe the invention of the boring academic paper to Boyle. Boyle developed a …
we probably owe the invention of the boring academic paper to Boyle. Boyle developed a …
[CITATION][C] Cardiac safety/events in clinical trials with preventive HIV vaccine candidates based on Modified vaccinia Ankara (MVA)
…, D Ho, M Keefer, VD Ramanathan, B Rosanne… - 2008 - erepository.uonbi.ac.ke
… Rosanne, Boyle … Schmidt C, Kochhar S, Excler JL, Smith C, McMichael A, Bwayo J,
Jaoko WG, Weber J, Kaleebu P, Peters B, Pantaleo G, Vardas E, Robinson A, Ho D, Keefer …
Jaoko WG, Weber J, Kaleebu P, Peters B, Pantaleo G, Vardas E, Robinson A, Ho D, Keefer …